Skip to main content

IgG subclass deposition in diabetic nephropathy

Abstract

Purpose

This study aimed to analyze the distribution of IgG subclass in diabetic nephropathy (DN) and its association with clinicopathological features.

Methods

This is a single-center retrospective study enrolling 108 patients with biopsy-proven DN. Immunofluorescence and immunohistochemistry staining were applied, and clinicopathological features and renal outcomes were compared between patients with different patterns or categories of IgG subclass deposition.

Results

Both IgG and its subclasses colocalized with collagen IV α5 on glomerular basement membrane (GBM) and some of tubular basement membrane (TBM). IgG1 and the Mixed type were two predominant types of deposition, no matter on GBM or TBM, and IgG1 showed a much higher deposition rate on GBM than that on TBM (P = 0.004). IgG subclass deposit on multi-location was more associated with a shorter duration of nephropathy and severer tubular interstitial injury (P < 0.05). The mixed type of IgG subclass deposit on GBM was merely associated with higher levels of proteinuria, whereas the deposition on TBM was more associated with higher levels of proteinuria, lower levels of albumin, more KIM-1 positive area, and thicker TBM (P < 0.05). Survival analysis revealed that none of the pattern or the category of IgG subclass deposit was a risk factor or a renal outcome indicator.

Conclusions

IgG subclass was selectively deposited along GBM and/or TBM in DN, and the mixed type of IgG subclass deposition on TBM had more clinical significance than the isotype and that on GBM. IgG subclass deposition is merely a manifestation or a consequence rather than a cause in DN.

Introduction

Diabetic nephropathy (DN) has a unique histological pattern, including glomerular basement membrane (GBM) thickening, mesangial expansion, and glomerulosclerosis, among others [1]. As a non-immunological related renal disease, the mechanism of IgG deposition along GBM and/or tubular basement membrane (TBM) in some DN cases is unclear [2]. This linear pattern cannot be detected by standard electron microscopy in DN, which is different from its deposition in immune complex-related glomerular diseases, such as membranous nephropathy (MN) [2]. Some hypotheses suggest that structural changes in the basement membrane lead to the entrapment of serum proteins, including albumin and IgG [3, 4]. One study demonstrated that up to 51.5% of the DN biopsies were IgG-positive, and the IgG intensity was associated with the progression of renal injury [2].

IgG has four subclasses (IgG1–G4); each subclass has a unique profile regarding half-life, antigen binding, immune complex formation, complement activation, and triggering of effector cells. Oxelius VA found that serum IgG2 and IgG3 levels declined, while IgG1 and IgG4 were relatively normal in juvenile diabetes mellitus (DM) cases [5]. Susanna M et al. found that serum IgG4 was selectively eliminated, and urinary IgG4 could be a helpful marker for preclinical stages of diabetic nephropathy [6]. Hemminger J et al. conducted a large retrospective study of IgG subclasses in 1084 routine renal biopsy cases regardless of the diagnosis and found that IgG4-dominant/codominant deposition with PLA2R-positive status was associated with primary MN, while IgG1 dominant/codominant with weak or absent IgG4 deposition was associated with autoimmune disease-related MN [7]. However, no IgG subclass in DN was included in this study. In 1984, Melvin T et al. studied IgG subclass in nine DN cases and found that only IgG4 had the same glomerular linear deposition as IgG [8]. This is difficult to explain considering the IgG profiles, since IgG4 has an anionic charge and the lowest serum concentration compared with the other subclasses, and GBM is anionically charged as well [6, 9]. Furthermore, the effect of tubular IgG deposition has not been studied. Therefore, we demonstrated the distribution of IgG subclass in 108 DN cases and analyzed its association with clinicopathological features and renal outcomes to explore the mechanism of IgG subclass deposition.

Materials and methods

Patients

Among 348 patients with type 2 DM and biopsy-proven DN between August 2017 and July 2021 at Hangzhou TCM Hospital Affiliated to Zhejiang Chinese Medical University, 225 cases showed an IgG linear pattern by immunofluorescence (IF). One hundred eight patients were enrolled according to the following inclusion criteria: (1) type 2 DM; (2) a diagnosis of DN proven by kidney biopsy; (3) IF showed IgG-positive status; and (4) Four IgG subclasses could be fully applied. The exclusion criteria were: (1) coexistence of nondiabetic renal diseases, such as MN, IgAN, or system diseases; (2) absence of glomeruli or global sclerosis in IF specimens; and (3) anti-GBM positive cases. The study was approved by the ethical committees of Hangzhou TCM Hospital Affiliated to Zhejiang Chinese Medical University (2020LH001).

Clinicopathological characteristics and outcomes

The following clinical information was collected: age, gender, duration of diabetes, duration of nephropathy (start from the nephropathy symptoms such as lower extremities edema or soreness of waist till the diagnosis of DN), 24-h proteinuria, serum albumin, serum creatinine (Scr), and the estimated glomerular filtration rate (eGFR, calculated by the Chronic Kidney Disease Epidemiology Collaboration formula).

All specimens were processed for light microscopy (LM), IF, immunohistochemistry (IHC), and electron microscopy (EM). Patients were grouped according to the pattern of IgG subclass deposition (locating on GBM, TBM, or Both) and the category of deposition (the None group: no IgG subclass deposition; the Isotype group: deposition with only one IgG subclass; the Mixed group: deposition with more than two types of IgG subclass). Classification of DN and histological scoring were done according to the criteria reported by Tervaert et al. [1]. Interstitial fibrosis and tubular atrophy (IFTA, 0–3 score), as well as inflammation (0–2 score), arteria hyalinosis, and sclerosis (0–3 score), were scored according to methods described by the previous study [1]. Diagnosis, classification, and the score of these pathological findings were evaluated and confirmed by two renal pathologists. GBM thickness was measured by electron microscopy, and TBM thickness was measured by light microscopy according to studies reported by Haas and Tyagi I [10, 11]. Foot process effacement (FPE) was graded according to its severity (1–3 score) [12].

Patients were contacted by telephone, and the follow-up data included renal function (proteinuria and eGFR), dialysis, or kidney transplantation. The outcomes were progression to end stage renal disease (ESRD) or ≥ 50% decline in eGFR from baseline. ESRD was defined as eGFR < 15 mL/min/1.73 m2 or initiation of chronic renal replacement therapy.

Immunofluorescence and immunohistochemistry staining

Frozen tissues were used for IgG (#F0202; 1:50, DAKO, Denmark) and IgG subclass (IgG1–IgG4, #F0767, #F4516, #F4641, #F9890, 1:50, Sigma-Aldrich, USA) staining by direct IF. Double staining of IgG or IgG subclass with anti-human collagen IV α5 (#C-452, 1:100, Cosmo corporation, Japan) by indirect IF (AF594 of Donkey anti-rat IgG as a secondary antibody, 1:100, Life Technologies, USA) was also performed. An Olympus BX53 fluorescence microscope (Japan) was used to analyze the IF slides.

IHC for kidney injury molecular-1 (KIM-1, #14,971, 1:200, Cell Signaling Technology, USA) and CD34 (ab81289, 1:100 titer, Abcam, Britain) was conducted using a Ventana BenchMark XT system. CD34 and KIM-1 positive statuses were analyzed by ImageJ and calculated as the percentage of positive area per glomeruli or cortex, respectively [13, 14].

Statistical analysis

Statistical analysis was performed with SPSS 17.0. Normally distributed data were expressed as mean ± standard deviation, and non-normally distributed data were expressed as medians and interquartile ranges. A comparison of clinical and pathological characteristics among groups was assessed by t test or ANOVA for continuous variables and nonparametric tests for discontinuous variables. Categorical variables were expressed as percentages and comparisons among groups, which were evaluated by chi-square test or the Fisher’s exact test. The association between IgG subclass deposition and renal outcomes was evaluated using Cox proportional hazards models. The renal survival rates between patients with different patterns or categories of IgG subclass deposition were calculated using log-rank test and Kaplan–Meier analysis. A P value of less than 0.05 was considered significant.

Results

Demographics of clinicopathological features

At the time of renal biopsy of all 108 cases, the average age was 53.8 ± 9.3 years, and 77 cases comprised males. The median duration of type 2 DM and nephropathy was 96 (36, 120) and 2 (1, 12) months, respectively. Most of the patients enrolled in our study had nephrotic syndrome (the median urinary protein was 3.7 (1.4, 6.9) g/day and the median serum albumin was 30.9 (26.2, 37.2) g/L), with normal to a moderate reduction of renal function (median Scr 112.5 (75.0, 150.8) umol/L and median eGFR 65.0 (39.0, 102.0) ml/min per 1.73m2, respectively). Renal biopsy showed 65% of DN were in stage three. On average, the pathological features showed 23.1% glomerulosclerosis, moderate to severe FPE, and moderate IFTA. All cases had minor to moderate linear IgG expression along the GBM, similar to albumin, but only 56.5% of cases showed linear TBM deposition (Fig. 1A). IgG globally colocalized with collagen IV α5 along GBM but focally along TBM (Fig. 1A). All cases showed negative or trace complements (C3, C4, C1q) along GBM or TBM (Fig. 1B).

Fig. 1
figure 1

Linear deposition of IgG and IgG1 in diabetic nephropathy. A Glomerular linear IgG expression (Green), collagen IV α5 expression (Red), and colocalization of IgG and collagen IV α5 in glomeruli (IF, × 200); B negative C3, C4, and C1q in the same biopsy of figure A (IF, × 200); C glomerular linear IgG1 expression (Green), collagen IV α5 expression (Red), and colocalization of IgG1 and collagen IV α5 in glomeruli (IF, × 200)

Association between IgG subclass location and clinicopathological features

One hundred cases showed one or more kinds of IgG subclass deposition along the GBM and/or TBM with a similar intensity of IgG, and the global linear deposition was colocalized with collagen IV α5 expression as well (Fig. 1C). IgG subclass showed higher frequency of deposition on GBM than that on TBM (87.0% vs 51.9%, P < 0.001) (Fig. 2). Among four kinds of IgG subclass deposit on GBM, cases of single IgG subclass accounted for 56.4%, with predominant IgG1 (41.7%), followed by IgG2 (10.2%), IgG3 (3.7%) and IgG4 (0.9%); in addition, mixed IgG subclass deposit accounted for 30.6%, and no deposit accounted for 13%. On the other hand, single IgG subclass deposit on TBM accounted for 37%, with predominant IgG1 (23.1%) as well, followed by IgG2 (5.6%), IgG3 (7.4%), and IgG4 (0.9%); in addition, mixed IgG subclass deposit accounted for 19.4%, and no deposit accounted for 43.5%. IgG1 showed a much higher deposition rate on GBM than that on TBM (P = 0.004) (Fig. 2). In the Mixed group, IgG1 and IgG2 had a higher deposition rate than IgG3 and IgG4 on GBM and/or TBM (P < 0.01), and IgG2 showed a higher deposition rate on GBM than that on TBM (P < 0.05) (Fig. 2).

Fig. 2
figure 2

IgG subclass distribution on GBM and TBM. A Proportion of different types of IgG subclass deposit on GBM and TBM; B proportion of four IgG subclasses on GBM and TBM in the mixed group

Forty-four cases showed IgG subclass deposition along GBM only (the GBM-only group), whereas six were positive along TBM only (the TBM-only group). The remaining fifty cases had positive staining on both GBM and TBM (the Both group) (Table 1). None of the clinical features had significant differences between groups except that the duration of nephropathy was shorter in the TBM-only group than in the GBM-only group (P = 0.021). Pathological features, such as KIM-1 showed more positive area, and TBM exhibited thicker in the Both deposition group than in the GBM-only group (P < 0.05) (Table 1).

Table 1 Clinicopathological associations among different groups based on IgG subclass distribution

Association between IgG subclass deposition on GBM and clinicopathological features

Ninety-four cases showed IgG subclass deposit on GBM, including 61 cases from the Isotype group and 33 cases from the Mixed group (Table 2). None of the clinicopathological data showed a significant difference, except that proteinuria exhibited much higher in the Mixed group than that in the Isotype group and the None group (P = 0.018) (Fig. 3).

Table 2 Clinicopathological findings of IgG subclass deposit on GBM
Fig. 3
figure 3

Types of IgG subclass and their pathological features. Thicker TBM and more KIM-1 positive area were observed in the isotype and the mixed group than in the none group. (IgG subclass: IF, × 200; PAS: × 200; KIM-1: IHC, × 200)

Association between IgG subclass deposition on TBM and clinicopathological features

TBM showed a much lower frequency (56.5%) of IgG subclass deposit than GBM, including 37% from the Isotype group and 19.5% from the Mixed group (Table 3). The clinicopathological data showed a shorter duration of nephropathy, more KIM-1 positive area and thicker TBM in the Isotype and the Mixed group than in the None group (P < 0.05); meanwhile, higher levels of proteinuria and lower levels of serum albumin exhibited in the Mixed group than in the Isotype group and the None group (P < 0.05).

Table 3 Clinicopathological findings of IgG subclass deposit on TBM

Survival analysis

The survival analysis presented that none of any IgG subclass or the pattern of deposition was a risk factor for renal outcomes by Cox regression analysis, as well as no significant survival difference was found among different deposition groups by log-rank test.

Discussion

In our study, 64.7% of the DN cases showed linear IgG staining by IF, lower than that reported by Mise K but higher than that of Zhang J [2, 15]. Unlike other immune complex-mediated glomerular nephropathy, such as membranous nephropathy, both IgG and albumin showed linear deposition but without dense deposits along GBM and TBM, and complements were negative. Furthermore, eluates from DN kidneys did not contain anti-GBM antibody as reported [16]. Those manifestations suggest that this kind of IgG deposition might occur more frequently as a manifestation or a consequence of renal injury [3, 4, 17].

IgG subclass is a useful diagnostic tool for several renal diseases, including MN, heavy and light chain deposition disease, proliferative glomerulonephritis with polyclonal IgG deposition, etc. [7]. The different locations of IgG subclass deposition are determined by both immunoglobulin profiles and the local environment. While the molecular size is similar among the four subclasses of IgG, the charge and serum concentration decreased in the order of IgG1, IgG2, IgG3, and IgG4 [6, 9, 18, 19]. Owing to the anionic charge feature of GBM, the affinity of IgG subclass to GBM should be higher for IgG1 and IgG2 than that of IgG4 [20, 21]. Zhang et al. reported that IgG1 deposit along the GBM and TBM tended to be prevalent in IgG positive patients with DN. However, no correlation was found between the IgG subclass distribution along the GBM and clinicopathological data or renal prognosis of DN patients [15]. In our study, IgG1 and the mixed type with predominant IgG1 and IgG2 were two major types of IgG subclass deposition, no matter on GBM or TBM, which was partly consistent with Zhang et al. [15]. We suspect the cationic charge of IgG1 plays the main role of deposition.

The deposition pattern of IgG subclass showed that GBM-only and multi-location deposits were predominant in DN. IgG subclass deposits on multi-location was more associated with a shorter duration of nephropathy and severer tubular interstitial injury, which shows multi-location deposit of IgG subclass indicates rapid progression of DN to some extent, though there was no significant findings of the association between the location and renal outcomes after survival analysis. Furthermore, the deposition of IgG subclass on TBM was diffuse, and the location of deposition did not show any preference of proximal or distal tubules; meanwhile, both preserved and injured tubules exhibited the same intensity of IgG subclass deposition, which suggests the mechanism of TBM deposition might be not only due to the re-absorption of proximal tubules but also the leakage of peritubular capillaries around [22].

To explore the category of IgG subclass deposit on GBM, we divided them into three groups according to the number of types of subclass deposits. Out of our expectations, no significant difference except higher levels of proteinuria was observed in the Mixed group than in the Isotype group. We suspect it might be due to the complexity of the structure of GBM (probably charge property, pore size, and slit diagram) and the crosstalk between endothelial cells and podocytes [17,18,19,20,21, 23, 24]. However, the TBM deposition of IgG subclass seemed to have more clinicopathological significance, which had always been overlooked by pathologists. In our study, some of the clinical and pathological data showed that more kinds of IgG subclass deposition were associated with severer injuries of both glomeruli and tubules, which reminds pathologists and nephrologists that more attention should be paid to the location of TBM deposition and the mixed type of IgG subclass rather than that of GBM deposition and the isotype deposition.

It’s reported that the glomerular IgG deposit emerged as an independent risk factor for renal clinical outcomes [15]. However, the survival analysis in our study revealed that neither the type of IgG subclass nor the deposition pattern was a risk factor or to be associated with renal outcome. We suspect the deposition of IgG subclass is merely a manifestation or a consequence, as we speculated from the pathological features above, which would not have an impact on the prognosis of DN. The limitation of this study is the single-center experience, which needs multi-center confirmation.

In summary, the location and the category of IgG subclass deposit are probably determined by their profiles and the severity of glomerular/tubular injury. The mixed type of IgG subclass deposition on TBM had more clinical significance than the isotype and that on GBM. IgG subclass deposition is merely a manifestation or a consequence rather than a cause in DN.

Availability of data and materials

The data sets used or analysed during the current study are available from the corresponding author on reasonable request.

Abbreviations

DN:

Diabetic nephropathy

GBM:

Glomerular basement membrane

TBM:

Tubular basement membrane

MN:

Membranous nephropathy

DM:

Diabetes mellitus

IF:

Immunofluorescence

Scr:

Serum creatinine

eGFR:

Estimated glomerular filtration rate

LM:

Light microscopy

IHC:

Immunohistochemistry

EM:

Electron microscopy

IFTA:

Interstitial fibrosis and tubular atrophy

FPE:

Foot process effacement

ESRD:

End stage renal disease

KIM-1:

Kidney injury molecular-1

References

  1. Tervaert TW, Mooyaart AL, Amann K, Cohen AH, Cook HT, Drachenberg CB, et al. Pathologic classification of diabetic nephropathy. J Am Soc Nephrol. 2010;21(4):556–63. https://doi.org/10.1681/asn.2010010010.

    Article  PubMed  Google Scholar 

  2. Mise K, Hoshino J, Ueno T, Sumida K, Hiramatsu R, Hasegawa E, et al. Clinical implications of linear immunofluorescent staining for immunoglobulin G in patients with diabetic nephropathy. Diabetes Res Clin Pract. 2014;106(3):522–30. https://doi.org/10.1016/j.diabres.2014.09.051.

    Article  CAS  PubMed  Google Scholar 

  3. Ainsworth SK, Hirsch HZ, Brackett NC Jr, Brissie RM, Williams AV Jr, Hennigar GR. Diabetic glomerulonephropathy: histopathologic, immunofluorescent, and ultrastructural studies of 16 cases. Hum Pathol. 1982;13(5):470–8. https://doi.org/10.1016/s0046-8177(82)80030-0.

    Article  CAS  PubMed  Google Scholar 

  4. Miller K, Michael AF. Immunopathology of renal extracellular membranes in diabetes mellitus. Specificity of tubular basement-membrane immunofluorescence. Diabetes. 1976;25(8):701–8. https://doi.org/10.2337/diab.25.8.701.

    Article  CAS  PubMed  Google Scholar 

  5. Oxelius VA, Immunoglobulin G. (IgG) subclasses and human disease. Am J Med. 1984;76(3a):7–18. https://doi.org/10.1016/0002-9343(84)90314-0.

    Article  CAS  PubMed  Google Scholar 

  6. Morano S, Cancelli A, Bacci S, Frontoni S, Napoli A, Fallucca F, et al. The selective elimination of anionic immunoglobulins as a parameter of kidney damage in diabetes and diabetic pregnancy. J Diabet Complications. 1988;2(1):2–4. https://doi.org/10.1016/0891-6632(88)90016-5.

    Article  CAS  PubMed  Google Scholar 

  7. Hemminger J, Nadasdy G, Satoskar A, Brodsky SV, Nadasdy T. IgG subclass staining in routine renal biopsy material. Am J Surg Pathol. 2016;40(5):617–26. https://doi.org/10.1097/pas.0000000000000605.

    Article  PubMed  Google Scholar 

  8. Melvin T, Kim Y, Michael AF. Selective binding of IgG4 and other negatively charged plasma proteins in normal and diabetic human kidneys. Am J Pathol. 1984;115(3):443–6.

    CAS  PubMed  PubMed Central  Google Scholar 

  9. Morano S, Pietravalle P, De Rossi MG, Mariani G, Cristina G, Medici F, et al. A charge selectivity impairment in protein permselectivity is present in type 2 diabetes. Acta Diabetol. 1993;30(3):138–42. https://doi.org/10.1007/bf00572857.

    Article  CAS  PubMed  Google Scholar 

  10. Haas M. Thin glomerular basement membrane nephropathy: incidence in 3471 consecutive renal biopsies examined by electron microscopy. Arch Pathol Lab Med. 2006;130(5):699–706. https://doi.org/10.5858/2006-130-699-tgbmni.

    Article  PubMed  Google Scholar 

  11. Tyagi I, Agrawal U, Amitabh V, Jain AK, Saxena S. Thickness of glomerular and tubular basement membranes in preclinical and clinical stages of diabetic nephropathy. Ind J Nephrol. 2008;18(2):64–9. https://doi.org/10.4103/0971-4065.42336.

    Article  CAS  Google Scholar 

  12. Hommos MS, De Vriese AS, Alexander MP, Sethi S, Vaughan L, Zand L, et al. The incidence of primary vs secondary focal segmental glomerulosclerosis: a clinicopathologic study. Mayo Clin Proc. 2017;92(12):1772–81. https://doi.org/10.1016/j.mayocp.2017.09.011.

    Article  PubMed  Google Scholar 

  13. Masum MA, Ichii O, Elewa YHA, Nakamura T, Kon Y. Local CD34-positive capillaries decrease in mouse models of kidney disease associating with the severity of glomerular and tubulointerstitial lesions. BMC Nephrol. 2017;18(1):280. https://doi.org/10.1186/s12882-017-0694-3.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Hwang S, Park J, Kim J, Jang HR, Kwon GY, Huh W, et al. Tissue expression of tubular injury markers is associated with renal function decline in diabetic nephropathy. J Diabetes Complications. 2017;31(12):1704–9. https://doi.org/10.1016/j.jdiacomp.2017.08.009.

    Article  PubMed  Google Scholar 

  15. Zhang J, Zhang J, Zhang R, Wang Y, Liang Y, Yang Z, et al. Implications of immunoglobulin G deposit in glomeruli in Chinese patients with diabetic nephropathy. J Diabetes. 2020;12(7):521–31. https://doi.org/10.1111/1753-0407.13024.

    Article  CAS  PubMed  Google Scholar 

  16. Gallo GR. Elution studies in kidneys with linear deposition of immunoglobulin in glomeruli. Am J Pathol. 1970;61(3):377–94.

    CAS  PubMed  PubMed Central  Google Scholar 

  17. Gambara V, Mecca G, Remuzzi G, Bertani T. Heterogeneous nature of renal lesions in type II diabetes. J Am Soc Nephrol. 1993;3(8):1458–66. https://doi.org/10.1681/asn.v381458.

    Article  CAS  PubMed  Google Scholar 

  18. Vidarsson G, Dekkers G, Rispens T. IgG subclasses and allotypes: from structure to effector functions. Front Immunol. 2014;5:520. https://doi.org/10.3389/fimmu.2014.00520.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Hui GK, Gardener AD, Begum H, Eldrid C, Thalassinos K, Gor J, et al. The solution structure of the human IgG2 subclass is distinct from those for human IgG1 and IgG4 providing an explanation for their discrete functions. J Biol Chem. 2019;294(28):10789–806. https://doi.org/10.1074/jbc.RA118.007134.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Deckert T, Feldt-Rasmussen B, Djurup R, Deckert M. Glomerular size and charge selectivity in insulin-dependent diabetes mellitus. Kidney Int. 1988;33(1):100–6. https://doi.org/10.1038/ki.1988.16.

    Article  CAS  PubMed  Google Scholar 

  21. Lindström KE, Johnsson E, Haraldsson B. Glomerular charge selectivity for proteins larger than serum albumin as revealed by lactate dehydrogenase isoforms. Acta Physiol Scand. 1998;162(4):481–8. https://doi.org/10.1046/j.1365-201X.1998.0316f.x.

    Article  PubMed  Google Scholar 

  22. Bryniarski MA, Yee BM, Jaffri I, Chaves LD, Yu JA, Guan X, et al. Increased megalin expression in early type 2 diabetes: role of insulin-signaling pathways. Am J Physiol Renal Physiol. 2018;315(5):F1191–207. https://doi.org/10.1152/ajprenal.00210.2018.

    Article  PubMed  Google Scholar 

  23. Ziyadeh FN, Wolf G. Pathogenesis of the podocytopathy and proteinuria in diabetic glomerulopathy. Curr Diabetes Rev. 2008;4(1):39–45. https://doi.org/10.2174/157339908783502370.

    Article  CAS  PubMed  Google Scholar 

  24. Fu J, Lee K, Chuang PY, Liu Z, He JC. Glomerular endothelial cell injury and cross talk in diabetic kidney disease. Am J Physiol Renal Physiol. 2015;308(4):F287–97. https://doi.org/10.1152/ajprenal.00533.2014.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We thank Pro. Yunqin Hu kindly provided diagnosis support, and Yu Fan kindly offered technical support.

Funding

This work was supported by grants from the Zhejiang Medical and Health Plan [2021KY924, 2022KY1002], National Science Foundation for Young Exploration Scholar of Zhejiang Chinese Medical University [2021JKZKTS037A], National Science Foundation of Zhejiang Province (LQ20H29003, LQ19H290005]), Zhejiang Traditional Chinese Medicine Administration (2020ZB154).

Author information

Authors and Affiliations

Authors

Contributions

XT contributed to the study design, fund support, and paper draft; FW performed the pathological analyses and technical support; QZ and TY contributed to the fund and clinical data analyses; XJ contributed to the fund and supervision, HY provided instruction and mentorship. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Xue Jiang.

Ethics declarations

Ethics approval and consent to participate

All procedures performed in studies involving human participants were by the ethical standards of the Institutional Review Board of Hangzhou TCM Hospital Affiliated to Zhejiang Chinese Medical University and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards [2020LH001].

Consent for publication

Written informed consent for publication was waived from all participants.

Competing interests

The authors declare that there is no conflict of interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tang, X., Wan, F., Zhu, Q. et al. IgG subclass deposition in diabetic nephropathy. Eur J Med Res 27, 147 (2022). https://doi.org/10.1186/s40001-022-00779-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s40001-022-00779-9

Keywords